T B Strom|J P Merrill - JoVE Visualize

Showing results (181-190 of 270) with videos related to

Pageof 27

Sort By:

Vox Sanguinis|May 1, 1981

A patient with post-hepatitis B immune deficiency: nonspecific helper factor partially restores the in vitro immune responseM J Sheehy, N J Miller, J M Rappeport, et al.

The Journal of Pharmacology and Experimental Therapeutics|January 1, 1995

5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cellsC Stevens, M Lipman, S Fabry, et al.

Transplantation|June 30, 1998

Increased CD40 ligand gene expression during human renal and murine islet allograft rejectionX X Zheng, A D Schachter, L Vasconcellos, et al.

Journal of Immunology (Baltimore, Md. : 1950)|August 24, 1999

Induction of allograft tolerance in the absence of Fas-mediated apoptosisX C Li, Y Li, I Dodge, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1984

Cyclosporine therapy of rat heart allograft recipients and release of interleukins (IL 1, IL 2, IL 3): a role for IL 3 in graft tolerance?M Abbud-Filho, J W Kupiec-Weglinski, J L Araujo, et al.

Transplantation|November 22, 2000

Interleukin-2 and interferon-gamma double knockout mice reject heterotopic cardiac allograftsM S Zand, Y Li, W Hancock, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 10, 1999

Antigen-induced unresponsiveness results in altered T cell signalingD B McKay, H Y Irie, G Hollander, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989

Sequential effects of interleukin 2-diphtheria toxin fusion protein on T-cell activationG Walz, B Zanker, K Brand, et al.

Protein Engineering|December 1, 1987

Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion proteinD P Williams, K Parker, P Bacha, et al.

Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1985

The events of primary T cell activation can be staged by use of Sepharose-bound anti-T3 (64.1) monoclonal antibody and purified interleukin 1J M Williams, D Deloria, J A Hansen, et al.

Pageof 27

Showing results (181-190 of 270) with videos related to

Sort By:

Pageof 27

Vox Sanguinis|May 1, 1981

A patient with post-hepatitis B immune deficiency: nonspecific helper factor partially restores the in vitro immune responseM J Sheehy, N J Miller, J M Rappeport, et al.

The Journal of Pharmacology and Experimental Therapeutics|January 1, 1995

5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cellsC Stevens, M Lipman, S Fabry, et al.

Transplantation|June 30, 1998

Increased CD40 ligand gene expression during human renal and murine islet allograft rejectionX X Zheng, A D Schachter, L Vasconcellos, et al.

Journal of Immunology (Baltimore, Md. : 1950)|August 24, 1999

Induction of allograft tolerance in the absence of Fas-mediated apoptosisX C Li, Y Li, I Dodge, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1984

Cyclosporine therapy of rat heart allograft recipients and release of interleukins (IL 1, IL 2, IL 3): a role for IL 3 in graft tolerance?M Abbud-Filho, J W Kupiec-Weglinski, J L Araujo, et al.

Transplantation|November 22, 2000

Interleukin-2 and interferon-gamma double knockout mice reject heterotopic cardiac allograftsM S Zand, Y Li, W Hancock, et al.

Journal of Immunology (Baltimore, Md. : 1950)|December 10, 1999

Antigen-induced unresponsiveness results in altered T cell signalingD B McKay, H Y Irie, G Hollander, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989

Sequential effects of interleukin 2-diphtheria toxin fusion protein on T-cell activationG Walz, B Zanker, K Brand, et al.

Protein Engineering|December 1, 1987

Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion proteinD P Williams, K Parker, P Bacha, et al.

Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1985

The events of primary T cell activation can be staged by use of Sepharose-bound anti-T3 (64.1) monoclonal antibody and purified interleukin 1J M Williams, D Deloria, J A Hansen, et al.

Pageof 27